Track topics on Twitter Track topics that are important to you
New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases. Xofigo shown in a pivotal phase III trial to significantly improve overall survival. Xofigo® with...
The next generation of p38 mitogen-activated protein kinase (MAPK) inhibitors has reached clinical proof-of-concept studies in phase II in a broad range of indications. While the previous generation o...
The latest and final in a series of congressionally mandated biennial reviews of the evidence of health problems that may be linked to exposure to Agent Orange and other herbicides used during the Vie...
In patients with Graves’ hyperthyroidism, predictive factors for Graves’ orbitopathy include older age of disease onset, longer disease duration and smoking, according to recent findings in a larg...
The addition of immunosuppressive drugs to the standard treatment of Graves’ disease may reduce the risk for relapse, according to study data. Tristan Mirko Struja, MD, of the department of medicine...
THURSDAY, March 10, 2016 -- There is stronger evidence of a link between the herbicide Agent Orange and bladder cancer and thyroid problems among U.S. military personnel exposed to the chemical during...
In this review, the advantages and disadvantages of available treatment options for young patients with Graves disease are discussed. Clinical Endocrinology
A new literature-based algorithm provides guidance for physicians on managing neonates born to mothers with Graves' disease (GD). Reuters Health Information
Just the other day a long-term patient presented with acute onset diplopia. While her demographic profile and clinical findings were consistent with a subtle ischemic sixth nerve palsy, my differentia...
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. There has been a long-running scare campaign against the commonly-used herbicide 2,4-D, whic...
Graves' disease is the most common cause of hyperthyroidism in iodine-replete areas. Although progress has been made in our understanding of the pathogenesis of the disease, no treatment targeting pat...
Treatment options for Graves' disease (GD), namely anti-thyroid drugs (ATD), surgery or radioiodine (RAI), have not changed over the past two decades. There is no 'gold-standard' treatment for GD.
The development of Graves' disease (GD) after subacute thyroiditis (SAT) is very rare and only a limited number of cases have been reported.
Thyrotropin Receptor Antibody (TRAb)-IgM Levels Are Markedly Higher Than TRAb-IgG Levels in Graves' Disease Patients and Controls, and TRAb-IgM Production Is Related to Epstein-Barr Virus Reactivation.
Graves' disease is an autoimmune thyroid disorder that mainly presents as hyperthyroidism and is caused by thyrotropin receptor antibodies (TRAbs) that stimulate thyroid-stimulating hormone receptors....
Graves' disease is an autoimmune disease caused by the production of auto-antibodies against the thyroid-stimulating hormone receptor, which stimulates follicular cell production of thyroid hormone. I...